Consenso 2018 de la Sociedad Española de Anatomía Patológica y la Sociedad Española de Oncología Médica sobre el diagnóstico y tratamiento del cáncer de origen desconocido

Matías-Guiu, Xavier; Fusté, Victòria; Iglesias, Lara; Balañá, Carmen; Concha, Ángel; Cruz-Merino, Luis de la; Nieto, Beatriz; Pané, Maria; Sanz, Julián; Losa, Ferran.
Rev. esp. patol ; 52(1): 33-44, ene.-mar. 2019. ilus, tab, graf
Artículo en Español | IBECS (España) | ID: ibc-182665

Documentos relacionados

  1. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.
  2. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary.
  3. Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
  4. [Genomic Analysis-Based Treatment for Cancer of Unknown Primary].
  5. Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
  6. Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary.
  7. Clinical features of cancer with unknown primary site (clinical features, treatment, prognosis of cancer with unknown primary site).
  8. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
  9. Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
  10. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.